SCHEMBL5954926

SCHEMBL5954926

NC(=O)c1ccccc1OS(=O)(=O)c1cc(I)c2occc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
CTNNB1 P35222 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
CFD P00746 1/20 0.33
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 3/20 0.33
POLB P06746 1/20 0.33
HSD17B10 Q99714 1/20 0.33
CA12 O43570 1/20 0.33
CA2 P00918 1/20 0.33
GAA P10253 1/20 0.33
PARP1 P09874 2/20 0.32
AKR1C1 Q04828 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
HTT P42858 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5805020 0.84 ALDH1A1 (0.40) MAPTCTNNB1L3MBTL1IRAK4ADORA2A
SCHEMBL5802580 0.84 KDM4E (0.37) MAPTCTNNB1L3MBTL1IRAK4ADORA2A
SCHEMBL5803267 0.76 CA1 (0.38) MAPTADORA2AALDH1A1KDM4EHSD17B10
SCHEMBL5806830 0.73 GRM2 (0.36)
SCHEMBL5803281 0.71 LMNA (0.39) MAPTL3MBTL1CA12CA2HTT
SCHEMBL1062600 0.67 CA1 (0.33) ALDH1A1HSD17B10CA12CA2
SCHEMBL7091675 0.65 CTNNB1 (0.55) MAPTCTNNB1L3MBTL1IRAK4ALDH1A1
SCHEMBL3792765 0.62 KDM4E (0.46) MAPTALDH1A1KDM4EHSD17B10GAA
SCHEMBL22891138 0.62 ALDH1A1 (0.35) ADORA2AADORA1ALDH1A1KDM4EHSD17B10
SCHEMBL28482368 0.62 MAPT (0.54) MAPTL3MBTL1ALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142269-A1 New compounds BIOVITRUM AB (SE) 2006-06-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142269-A1 New compounds GPR119, GLP1R, IAPP MAPT 1446/4885CTNNB1 4556/4885L3MBTL1 3026/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.